- Capital Cube•27 days ago
Click here to see latest analysisSIGA Technologies, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Sinovac Biotech Ltd., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink […] (Read more...) The post SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 appeared first on CapitalCube.
|52wk Range||0.60 - 2.55|
|Day's Range||2.20 - 2.50|
|Avg Vol (3m)||86,198|
As of 2:16 PM EDT. Other OTC Delayed Price. Market open.